National Health (Growth Hormone Program) Special Arrangement Amendment Instrument 2016 (No. 2) (PB 116 of 2016) (Cth)

PB 116 of 2016

National Health (Growth Hormone Program) Special Arrangement Amendment Instrument 2016 (No. 2)

National Health Act 1953

I, JULIANNE QUAINE, Assistant Secretary, Pharmaceutical Access Branch, Pharmaceutical Benefits Division, Department of Health, delegate of the Minister for Health and Aged Care, make this Instrument under subsection 100(2) of the National Health Act 1953.

Dated 21 DECEMBER 2016

JULIANNE QUAINE

Assistant Secretary

Pharmaceutical Access Branch

Pharmaceutical Benefits Division

Department of Health

1   Name of Instrument

(1)  This Instrument is the National Health (Growth Hormone Program) Special Arrangement Amendment Instrument 2016 (No.2).

(2)  This Instrument may also be cited as PB 116 of 2016.

2   Commencement

This Instrument commences on 1 January 2017.

3   Amendment of PB 85 of 2015

Schedule 1 amends the National Health (Growth Hormone Program) Special Arrangement 2015 (PB 85 of 2015).

Schedule 1     Amendments

1. Schedule 1, after the entry for the listed drug Somatropin in the form Injection 4 mg (12 i.u.) vial with diluent (with preservative)

omit:

Injection 8 mg (24 i.u.) vial with 1.37 mL diluent cartridge (with preservative) (for use with one.click auto-injector) Injection Saizen 8 mg click.easy D(100)